AMG-167
AMG-167 is an anti-cancer monoclonal antibody targeting sclerostin. AMG-167 can be studied in research for osteoporosis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1798349-30-0
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
IC50 & Target
SOST/Sclerostin
Aplicación
ELISA, FACS, Functional assay
Product Details
-
No. CAS 1798349-30-0
-
Accession Q9BQB4
-
Species Reactivity
Human
-
Conjugated
Unconjugated
Product Properties
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. MacNabb, C., et al., (2016). Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges. Journal of osteoporosis, 2016, 6217286. [Content Brief]
[2]. Dede, A. D., et al., (2017). Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments. Expert opinion on investigational drugs, 26(10), 1137–1144. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)